MS-432

N/A

Report date: 2023/03/02 13:36:08

NME

Base Information

Drug NameMS-432

Drug Alias NameMS-432MS432

ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)

Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase 1 degradersDual specificity mitogen-activated protein kinase kinase 2 degraders

TargetsDual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2

Therapy Area/IndicationsColorectal NeoplasmsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIcahn School Of Medicine At Mount Sinai

China Registration ClassN/A

Develop Information

Active CompaniesIcahn School Of Medicine At Mount Sinai

Inactive CompaniesN/A

Active IndicationsColorectal NeoplasmsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A